SPANOR 100 mg, film-coated tablet scored 30 tablets
Active ingredients: Doxycycline monohydrate, HYCLATE DE DOXYCYCLINE
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SPANOR 100 mg, comprimé pelliculé sécable
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 comprimé(s)
- Marketing authorisation holder
- LABORATOIRES BAILLEUL (LUXEMBOURG)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 28 Feb 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65333974CIP73559937CIP133400935599377Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DOXYCYCLINE HYDRATÉEcomprimé | 100 mg · un comprimé | FT |
| HYCLATE DE DOXYCYCLINEcomprimé | 100 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.